Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

9833	Companies
197406	Keywords
128489	Articles
104991	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 03/27/2024 at 09:01, 1 year 10 months ago

Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101
Heidelberg Pharma granted orphan drug designation by FDA for its ATAC candidate HDP-101, targeting multiple myeloma. The designation provides significant benefits for the development and potential marketing of the drug

FDA Orphan Drug Designation Heidelberg Pharma Multiple Myeloma ATAC Candidate
BRIEF

published on 03/25/2024 at 07:15, 1 year 10 months ago

Heidelberg Pharma AG Showcases Robust 2023 Performance and Financial Highlights

Cancer Therapy Financial Results 2023 ADC Technology Heidelberg Pharma AG HDP-101 Trial
BRIEF

published on 03/25/2024 at 07:15, 1 year 10 months ago

Heidelberg Pharma AG présente ses solides performances pour 2023 et ses faits saillants financiers

Résultats Financiers 2023 Technologie CAN Heidelberg Pharma SA Essai HDP-101 Thérapie Contre Le Cancer
PRESS RELEASE

published on 03/25/2024 at 07:10, 1 year 10 months ago

Heidelberg Pharma announces financial figures and reports on successful business performance in 2023
Heidelberg Pharma AG announces financial figures and successful business performance in 2023, including efficacy data from HDP-101 clinical trial. New Management Board team and expansion of ADC technology platform

Financial Results Business Performance HDP-101 ADC Technology Heidelberg Pharma AG
BRIEF

published on 03/19/2024 at 09:52, 1 year 10 months ago

Heidelberg Pharma Receives Upfront Payment from HealthCare Royalty Agreement

Heidelberg Pharma HealthCare Royalty Zircaix Antibody Drug Conjugates Biotech Funding
BRIEF

published on 03/19/2024 at 09:52, 1 year 10 months ago

Heidelberg Pharma reçoit un paiement initial dans le cadre d'un accord de redevances sur les soins de santé

Conjugués Anticorps-médicament Heidelberg Pharma Zircaix Redevance En Matière De Soins De Santé Financement Biotechnologique
PRESS RELEASE

published on 03/19/2024 at 09:47, 1 year 10 months ago

Heidelberg Pharma announces receipt of non-refundable upfront cash payment following the successful closing of its royalty purchase agreement with HealthCare Royalty
Heidelberg Pharma receives USD 25 million upfront cash payment from HealthCare Royalty for royalty purchase agreement. Funds to advance ADC pipeline development and extend cash runway

Heidelberg Pharma HealthCare Royalty ADC Pipeline Royalty Purchase Agreement Cash Payment
BRIEF

published on 03/18/2024 at 07:30, 1 year 10 months ago

Heidelberg Pharma Advances to Cohort 6 in Multiple Myeloma Study with HDP-101

Heidelberg Pharma HDP-101 Multiple Myeloma Phase I/IIa Study Cohort 6
BRIEF

published on 03/18/2024 at 07:30, 1 year 10 months ago

Heidelberg Pharma passe à la cohorte 6 dans l'étude sur le myélome multiple avec HDP-101

Heidelberg Pharma HDP-101 Myélome Multiple Étude De Phase I/IIa Cohorte 6
PRESS RELEASE

published on 03/18/2024 at 07:25, 1 year 10 months ago

Heidelberg Pharma announces progress into Cohort 6 with its proprietary ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study
Heidelberg Pharma progresses into Cohort 6 with ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study, showing first objective responses and partial remissions. Amended protocol includes optimized dosing regimens

Heidelberg Pharma Multiple Myeloma Phase I/IIa Study ATAC Candidate Protocol Amendment

Accesswire

Published on 02/10/2026 at 12:00, 16 minutes ago

Banyan Gold Strengthens Technical Team with Appointments of John Robins as Strategic Advisor and Key ESG Position
Published on 02/10/2026 at 09:01, 3 hours 15 minutes ago

Star Copper to Deploy Advanced Deep-Penetrating 3D IP to Expedite 2026 Drill Program
Published on 02/10/2026 at 09:01, 3 hours 15 minutes ago

Noram Fully Funded for 2026 and Engages GRE to Update PEA With Multiple High-Value Critical Mineral Byproduct Credits
Published on 02/10/2026 at 09:01, 3 hours 15 minutes ago

Apex Mobilizes Second Drill Rig and Provides Phase I Update at the Rift Rare Earth Project in Nebraska, U.S.A.
Published on 02/10/2026 at 08:00, 4 hours 16 minutes ago

Caledonia Mining Corporation Plc - Issue of Securities Pursuant to Long Term Incentive Plan Awards

View all ACCESSWIRE

EQS Group

Published on 02/10/2026 at 12:05, 10 minutes ago

IRBM Reports Breakthrough in Zika Virus Drug Discovery
Published on 02/10/2026 at 12:05, 10 minutes ago

Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy in acute leukemias with limited treatment options
Published on 02/10/2026 at 11:55, 20 minutes ago

Bybit Named Title Partner of Stockholm Open as Tournament Reclaims Historic identity
Published on 02/10/2026 at 11:35, 40 minutes ago

Maldives Launches Tech4Nature Project to Safeguard Iconic Whale Sharks
Published on 02/10/2026 at 11:20, 55 minutes ago

Amundi Physical Metals plc: UK Final Terms

Les Echos

Published on 02/09/2026 at 18:00, 18 hours 16 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 18 hours 31 minutes ago

Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 18 hours 31 minutes ago

DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 18 hours 31 minutes ago

Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 18 hours 31 minutes ago

Déclaration des droits de vote à fin janvier 2026

View all LES ECHOS COMFI WIRE